## **Core Concept**
Crescentic glomerulonephritis (GN) is a severe form of glomerulonephritis characterized by the presence of crescents in more than 50% of glomeruli. It is often associated with rapid deterioration of renal function. The prognosis of crescentic GN depends on several factors, including the underlying cause, severity of renal involvement, and promptness of treatment.
## **Why the Correct Answer is Right**
The correct answer, **C. Presence of anti-GBM antibodies and ANCA positivity along with prompt initiation of treatment**, highlights key factors influencing the prognosis of crescentic GN. Anti-GBM (Goodpasture's) disease and ANCA-associated vasculitis are two primary causes of crescentic GN. The presence of these autoantibodies helps in diagnosing the underlying cause and guides treatment. Prompt initiation of immunosuppressive therapy, including corticosteroids and sometimes plasmapheresis, significantly improves renal outcomes.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While the percentage of crescents can indicate disease severity, it is not the sole determinant of prognosis. Patients with high crescent formation can still recover with aggressive treatment.
- **Option B:** Although renal function at presentation is an important prognostic indicator, with higher creatinine levels associated with poorer outcomes, it is not the only factor. Other variables like the underlying etiology and treatment response also play critical roles.
## **Clinical Pearl / High-Yield Fact**
A crucial clinical pearl is that early diagnosis and treatment of crescentic GN, especially when caused by anti-GBM disease or ANCA-associated vasculitis, can significantly improve patient outcomes. The use of immunosuppressive therapy and, in some cases, plasmapheresis, has revolutionized the management of these conditions.
## **Correct Answer:** . Presence of anti-GBM antibodies and ANCA positivity along with prompt initiation of treatment
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.